Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma
Lijuan Liu(First Affiliated Hospital of Xi'an Jiaotong University), Fan Zhu(Wuhan University)
Cited by 15
Related Papers
Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation
|Hepatology|2012|85
Physicochemical and sensory properties of fresh noodles fortified with ground linseed (Linum usitatissimum)
|LWT|2018|49
Epigenetic addition of m5C to HBV transcripts promotes viral replication and evasion of innate antiviral responses
|Cell Death and Disease|2024|42
Whey protein hydrolysates and infant formulas: Effects on physicochemical and biological properties
|Comprehensive Reviews in Food Science and Food Safety|2024|33